Sbc Medical Group Holdings Incorporated (SBC) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Sbc Medical Group Holdings Incorporated  (NASDAQ: SBC)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Select the Financial Report: Select the Period:


Description of Sbc Medical Group Holdings Incorporated's Business Segments


The Company operates in a single segment, generating revenue primarily through comprehensive management services for franchisee cosmetic treatment centers. These services include advertising, staffing, procurement, IT solutions, and licensing of medical technologies and trademarks. The Company wholly owns SBC Medical Group, Inc. and SBC MEDICAL APAC PTE. LTD. SBC Medical Group, Inc. operates through 15 wholly owned subsidiaries—SBC Medical Group Co., Ltd., Liesta Co., Ltd., SBC Sealane Co., Ltd., SBC Marketing Co., Ltd., SBC Medical Consulting Co., Ltd., Shoubikai Medical Vietnam Co. Ltd., SBC Healthcare, Inc., SBC Irvine, LLC, Aesthetic Healthcare Holdings Pte., Ltd., Wen & Weng Family Clinic Pte., Ltd., Wen & Weng Medical Group Pte., Ltd., Rochor Clinic Pte., Ltd., Dermasolutions Pte., Ltd., Dermasolutions Services Pte., Ltd., and MB Career Lounge Co., Ltd.—and three majority owned subsidiaries: Medical Payment Co., Ltd., Waqoo, Inc., and Cell Pro Japan Co., Ltd., the latter being a wholly owned subsidiary of Waqoo. The Company also consolidates Aikawa Medical Management, Inc., its variable interest entity. Effective January 1, 2026, SBC Marketing Co., Ltd. merged into SBC Medical Group Co., Ltd. On January 7, 2026, the Company established SBC Medical M&A Advisory Co., Ltd. to provide healthcare-focused M&A advisory services. The Company sold its subsidiaries Kijimadaira Resort Inc. and Skynet Academy Co., Ltd. to entities owned by Yoshiyuki Aikawa, CEO, to focus on its core medical business; these disposals did not constitute a strategic shift with significant effects on operations or financial results.


Composition of Sbc Medical Group Holdings Incorporated Revenues by Segments

 
Franchising    37.83 % of total Revenue
Procurement Services    52.34 % of total Revenue
Management Services    50.38 % of total Revenue
Rental Services    14.87 % of total Revenue
Other    22.95 % of total Revenue
Product and Service Subtotal    178.36 % of total Revenue
Waqoo Segment    19.8 % of total Revenue
SBC Core Segment    178.37 % of total Revenue
Intersegment Elimination Segment    -10.63 % of total Revenue
Consolidated    187.54 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Franchising 18.61 37.83 %
Procurement Services 25.75 52.34 %
Management Services 24.78 50.38 %
Rental Services 7.31 14.87 %
Other 11.29 22.95 %
Product and Service Subtotal 87.73 178.36 %
Waqoo Segment 9.74 19.8 %
SBC Core Segment 87.74 178.37 %
Intersegment Elimination Segment -5.23 -10.63 %
Consolidated 92.25 187.54 %
Total 49.19 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Franchising - -
Procurement Services - -
Management Services - -
Rental Services - -
Other - -
Product and Service Subtotal - -
Waqoo Segment - -
SBC Core Segment - -
Intersegment Elimination Segment - -
Consolidated - -
Total 14.36 % 16.16 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Consolidated 36.68 39.76 %
Total 11.16 22.69 %




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Consolidated - -
Total 357.49 % -1.47 %




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.